Related Experiment Video
Updated: Jul 4, 2025
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Brucine Inhibits Proliferation of Pancreatic Ductal Adenocarcinoma through PI3K/AKT Pathway-induced Mitochondrial
You Wu1,2, Fenglin Zhang1,2, Panling Xu1,2
1Oncology Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Anhui Medical University, 230022, Hefei, Anhui, China.
Introduction:
The purpose of this research was to settle the role of brucine in pancreatic ductal adenocarcinoma (PDAC) and the mechanisms involved.
Methods:
The findings of this study suggest that brucine exerts inhibitory effects on cell growth, clonogenicity, and invasive potential of Panc02 and Mia Paca-2 cells. These effects may be linked to an increase in apoptotic-prone cell population.
Results:
Gene sequencing data suggests that these effects are mediated through the induction of apoptosis. Experimental evidence further supports the notion that brucine reduces mitochondrial membrane potential and upregulates Bax expression while downregulating Bcl-2 expression. These effects are believed to be a result of brucine-mediated suppression of PI3K/Akt activity, which serves as a regulatory factor of mTOR, Bax, and Bcl-2. Suppression of PI3K activity enhances the tumor-suppressing effects of brucine.
Conclusion:
Overall, these findings suggest that brucine has therapeutic potential as a remedy option for PDAC.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
01:22PI3K/mTOR/AKT Signaling Pathway
02:23Abnormal Proliferation
02:34Inhibition of Cdk Activity